Quadrant Capital »

ADC Therapeutics SA shares owned by Quadrant Capital

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $611 173 3.53
2025-09-30 $692 173 4.00

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Schwab Strategic Tr Fundamental Us L (FNDX)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Quadrant Capital

Top funds holding ADC Therapeutics SA

Redmile Group
Prosight Management
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
BlackRock
Eventide Asset Management
Goldman Sachs Group
State Street Corporation
TCG Crossover Management
Lynx1 Capital Management
Vanguard Group
Geode Capital Management
Platinum Investment Mangement
Citadel Advisors

View all funds holding ADC Therapeutics SA